Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Sermet

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Archives of Disease in Childhood|November 13, 2003
Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patientsI Sermet-Gaudelus, J C Souberbielle, I Azhar, et al.
Vaccine|June 21, 2014
Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosisO Launay, P Y Boelle, A Krivine, et al.
Mediators of Inflammation|March 7, 2000
Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary reportI Sermet-Gaudelus, V Stoven, J P Annereau, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 13, 2014
Effectiveness of bacteriophages in the sputum of cystic fibrosis patientsE Saussereau, I Vachier, R Chiron, et al.
The European Respiratory Journal|February 14, 2009
Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairmentsD Hubert, F Aubourg, B Fauroux, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 25, 2020
Penetrance is a critical parameter for assessing the disease liability of CFTR variantsA Boussaroque, M-P Audrézet, C Raynal, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 28, 2020
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF)M W Konstan, D R VanDevanter, S M Rowe, et al.
American Journal of Medical Genetics|December 5, 2000
Clinical variability and genetic homogeneity of the camptodactyly-arthropathy-coxa vara-pericarditis syndromeL Faivre, A M Prieur, M Le Merrer, et al.
Pathologie-Biologie|February 6, 2004
[Rotavirus nosocomial infection in pediatric units. A multicentric observation study]I Sermet-Gaudelus, F de La Rocque, J-L Salomon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 20, 2015
Vaccine coverage in CF children: A French multicenter studyA Masson, O Launay, B Delaisi, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Archives of Disease in Childhood|November 13, 2003
Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patientsI Sermet-Gaudelus, J C Souberbielle, I Azhar, et al.
Vaccine|June 21, 2014
Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosisO Launay, P Y Boelle, A Krivine, et al.
Mediators of Inflammation|March 7, 2000
Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary reportI Sermet-Gaudelus, V Stoven, J P Annereau, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 13, 2014
Effectiveness of bacteriophages in the sputum of cystic fibrosis patientsE Saussereau, I Vachier, R Chiron, et al.
The European Respiratory Journal|February 14, 2009
Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairmentsD Hubert, F Aubourg, B Fauroux, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 25, 2020
Penetrance is a critical parameter for assessing the disease liability of CFTR variantsA Boussaroque, M-P Audrézet, C Raynal, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 28, 2020
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF)M W Konstan, D R VanDevanter, S M Rowe, et al.
American Journal of Medical Genetics|December 5, 2000
Clinical variability and genetic homogeneity of the camptodactyly-arthropathy-coxa vara-pericarditis syndromeL Faivre, A M Prieur, M Le Merrer, et al.
Pathologie-Biologie|February 6, 2004
[Rotavirus nosocomial infection in pediatric units. A multicentric observation study]I Sermet-Gaudelus, F de La Rocque, J-L Salomon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 20, 2015
Vaccine coverage in CF children: A French multicenter studyA Masson, O Launay, B Delaisi, et al.
Pageof 8